Anzor Lagvilava MD. PhD.

• Open and laparoscopic diagnosis and surgical treatment of pathologies of abdominal organs (including stomach, liver, biliary tract, spleen, small and large intestine);
• Thoracoscopic diagnosis and surgical treatment of pathologies of chest organs (lungs, pleura and mediastinum);
• Thyroid surgery, including oncological diseases;
• Breast surgery, including oncological diseases.

• 2000-2006 – Tbilisi State Medical University,
• 2007-2012 – Tbilisi State Medical University, postgraduate education;
• 2012 – State certificate specialty “General surgery”;
• 2012-2013 – Tbilisi State Medical University, postgraduate education; Subspecialty certificate “Thoracic surgery”;
• 2013 – Subspecialty certificate “Surgical Oncology”;
• 2020-2023 – David Agmashenebeli University of Georgia, doctoral program – medicine, surgery direction. The Doctor of Medicine PhD degree was awarded.
• 2017-2018 – Training courses in leading Israeli clinics.

• 2006-2009 – Therapy House LLC, junior doctor.
• 2007-2012 – Tbilisi, I-st Clinical Hospital, General Surgery Clinic, Emergency Surgery Center, General Surgeon, Resident.
• 2010 – 2015 – Chemotherapy and Immunotherapy Clinic “Medula”, junior doctor, general surgeon 2012, thoracic surgeon 2013, surgeon-oncologist 2013.
• 2014 – New Hospital, surgical oncologist, thoracic surgeon, general surgeon.
• 2021-2022 – American Hospital Tbilisi, head of the general surgery department.
• Since 2024, General surgeon, surgical oncologist and thoracic surgeon of Zhordania Medical Center.

• Member of the European Society of Medical Oncology (ESMO);
• Member of the American Society of Medical Oncology (ASCO);
• Member of the European Emergency Surgery Association;
• Member of Grigol Mukhadze Association of Surgeons of Georgia;
• Member of Thoracic Surgery Association.

Participation in conferences and congresses:

• Participated in various local and international conferences and congresses.

Publications:

• The Author of 5 scientific publications (articles).
• Participants in 5 international clinical trials.

Knowledge of languages:

• Georgian – native
• Russian – fluent
• English – average
• German – average